Skip to main content

Clinical trial METASUN UCL-ONCO 2012-09

A proof of concept study to evaluate the use of metabonomics and lipidomics in predicting toxicity and efficacy of anti-VEGF therapy in patients with metastatic clear cell renal cell carcinoma

Cancers
Organ Kidney
Trial status Trial open for recruitment
Investigator
Trial type
Interventional with experimental drug
Academic trial Oui
Sponsor UCL St Luc
EudraCT Identifier 2011-006085-40
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02570789
Inclusion criteria Metastatic. RECIST v1.1
Last update